-
Tips for becoming a good boxer - November 6, 2020
-
7 expert tips for making your hens night a memorable one - November 6, 2020
-
5 reasons to host your Christmas party on a cruise boat - November 6, 2020
-
What to do when you’re charged with a crime - November 6, 2020
-
Should you get one or multiple dogs? Here’s all you need to know - November 3, 2020
-
A Guide: How to Build Your Very Own Magic Mirror - February 14, 2019
-
Our Top Inspirational Baseball Stars - November 24, 2018
-
Five Tech Tools That Will Help You Turn Your Blog into a Business - November 24, 2018
-
How to Indulge on Vacation without Expanding Your Waist - November 9, 2018
-
5 Strategies for Businesses to Appeal to Today’s Increasingly Mobile-Crazed Customers - November 9, 2018
Martin Shkreli: Fraud ‘allegations are baseless and without merit’ claims
Shkreli said on his live-stream Friday that he couldn’t discuss the allegations; instead, he thanked supporters.
Advertisement
The SEC has requested a jury trial in the case, in which it’s asking a court to order Shkreli and his lawyer, Evan Greebel, to “disgorge their ill-gotten gains”, to levy fines on the pair, and to bar them from serving as officers or directors of companies. However, the latest set of charges he faces are unrelated and just might stick.
Prior to his arrest and subsequent resignation from Turing, Shkreli spoke to Vanity Fair, comparing himself to a “hip-hop Rockefeller” and claiming that he isn’t affected by the criticism and scorn heaped upon him by media and consumers alike.
The charges state he used those resources to pay off debts from other business dealings, according to Bloomberg.
Over time, anger against Shkreli has intensified, moving from the investor-class to the general public because of news over the summer of hyper-inflating prices on a pill his company provided for life-threatening illnesses, simply for the fact that he could make money off of it. Shkreli is also chief executive of KaloBios Pharmaceuticals, which has not commented on his arrest.
Olivia Alair Dalton of the Human Rights Campaign said: “We hope that Martin Shkreli’s departure will mark the end of Turing Pharmaceuticals’ reckless price hikes on life-saving medications”.
Shkreli is a Brooklyn native who attended Hunter College High School in Manhattan, though he did not graduate, a school spokesperson told ABC News.
The FBI arrested Shkreli, 32, on Thursday morning in NY. Despite that, people said Shkreli would come back to Hunter frequently “in a suit and in a briefcase, hanging out in the hallways and sort of showing of”. In fact, he recently said he probably should have raised it more.
Hillary Clinton called it price-gouging and said the company’s behavior was “outrageous”.
The drug industry’s lobby group, Pharmaceutical Research and Manufacturers of America, has gone after both Valeant and Turing, saying in September that Turing doesn’t represent its values, and in October that Valeant’s strategy “is more reflective of a hedge fund than an innovative biopharmaceutical company”.
Advertisement
Martin Shkreli, the pharmaceutical executive facing US charges of securities fraud, lost control of his Twitter account to hackers on Sunday, hours after he took to Twitter to plead his innocence, his spokesman said. “At the same time, I am very excited about the opportunity to guide Turing Pharmaceuticals forward”.